NPS PHARMACEUTICALS INC's ticker is and the CUSIP is 62936P903. A total of 2 filers reported holding NPS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $2,490,000 | +5.8% | 69,600 | -23.1% | 0.00% | 0.0% |
| Q3 2014 | $2,353,000 | +40.1% | 90,500 | +78.1% | 0.00% | 0.0% |
| Q2 2014 | $1,679,000 | +71.5% | 50,800 | +55.4% | 0.00% | +100.0% |
| Q1 2014 | $979,000 | -40.8% | 32,700 | -40.0% | 0.00% | -50.0% |
| Q4 2013 | $1,655,000 | -15.4% | 54,500 | -11.4% | 0.00% | -33.3% |
| Q3 2013 | $1,956,000 | +127.7% | 61,500 | +8.1% | 0.00% | +200.0% |
| Q2 2013 | $859,000 | – | 56,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 66,200 | $1,000,000 | 0.02% |
| Citadel Advisors | 56,900 | $859,000 | 0.00% |